Evidence map›Paper›PMID 29044127›Full record

ArticleScientific reports2017

Engineered in-vitro cell line mixtures and robust evaluation of computational methods for clonal decomposition and longitudinal dynamics in cancer.

Hossein Farahani, Camila P E de Souza, Raewyn Billings, Damian Yap, Karey Shumansky, Adrian Wan, Daniel Lai, Anne-Marie Mes-Masson, Samuel Aparicio, Sohrab P Shah

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hossein FarahaniBC Cancer Agency, Department of Molecular Oncology, Vancouver, V5Z 1L3, Canada.
Camila P E de SouzaBC Cancer Agency, Department of Molecular Oncology, Vancouver, V5Z 1L3, Canada.
Raewyn BillingsBC Cancer Agency, Department of Molecular Oncology, Vancouver, V5Z 1L3, Canada.
Damian YapBC Cancer Agency, Department of Molecular Oncology, Vancouver, V5Z 1L3, Canada.ORCID 0000-0002-5370-4592
Karey ShumanskyBC Cancer Agency, Department of Molecular Oncology, Vancouver, V5Z 1L3, Canada.
Adrian WanBC Cancer Agency, Department of Molecular Oncology, Vancouver, V5Z 1L3, Canada.
Daniel LaiBC Cancer Agency, Department of Molecular Oncology, Vancouver, V5Z 1L3, Canada.
Anne-Marie Mes-MassonCentre de recherche du Centre hospitalier de l' Université de Montréal (CRCHUM), Montreal, Canada.
Samuel AparicioBC Cancer Agency, Department of Molecular Oncology, Vancouver, V5Z 1L3, Canada.
Sohrab P ShahBC Cancer Agency, Department of Molecular Oncology, Vancouver, V5Z 1L3, Canada. sshah@bccrc.ca.ORCID 0000-0001-6402-523X

Funding

CIHR MOP 126119
6 · The paper itself

Abstract

Characterization and quantification of tumour clonal populations over time via longitudinal sampling are essential components in understanding and predicting the response to therapeutic interventions. Computational methods for inferring tumour clonal composition from deep-targeted sequencing data are ubiquitous, however due to the lack of a ground truth biological data, evaluating their performance is difficult. In this work, we generate a benchmark data set that simulates tumour longitudinal growth and heterogeneity by in vitro mixing of cancer cell lines with known proportions. We apply four different algorithms to our ground truth data set and assess their performance in inferring clonal composition using different metrics. We also analyse the performance of these algorithms on breast tumour xenograft samples. We conclude that methods that can simultaneously analyse multiple samples while accounting for copy number alterations as a factor in allelic measurements exhibit the most accurate predictions. These results will inform future functional genomics oriented studies of model systems where time series measurements in the context of therapeutic interventions are becoming increasingly common. These studies will need computational models which accurately reflect the multi-factorial nature of allele measurement in cancer including, as we show here, segmental aneuploidies.

Indexed as

Computer SimulationModels, BiologicalAlgorithmsAnimalsBreast NeoplasmsCell Line, TumorComputational BiologyDisease Models, AnimalDNA Copy Number VariationsExome SequencingFemaleHeterograftsHumansMiceNeoplasmsPolymorphism, Single Nucleotide

Identifiers

PMID29044127
PMCPMC5647443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.